Identification of α-fodrin as a candidate autoantigen in primary Sjogren's syndrome

Science

Volumn 276, Issue 5312, 1997, Pages 604-607

  Haneji, Norio ^a   Nakamura, Takanori ^a   Takio, Koji ^b   Yanagi, Kumiko ^a   Higashiyama, Hiroyuki ^a   Saito, Ichiro ^a   Noji, Sumihare ^a   Sugino, Hiromu ^a   Hayashi, Yoshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; FODRIN; GAMMA INTERFERON; INTERLEUKIN 2; SPECTRIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN DETECTION; ANTIGEN PURIFICATION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; IMMUNOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SALIVARY GLAND; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; HUMANS; IMMUNIZATION; IMMUNOBLOTTING; INTERFERON TYPE II; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED STRAINS; MICROFILAMENT PROTEINS; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; RECOMBINANT FUSION PROTEINS; SALIVARY GLANDS; SJOGREN'S SYNDROME; T-LYMPHOCYTES;

EID: 0030999866     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.276.5312.604     Document Type: Article

References (37)

1. K. J. Bloch, W. W. Buchanan, M. J. Wohl, J. J. Bunim, Medicine 44, 187 (1965); E. K. L. Chan, J. C. Hamel, J. P. Buyon, E. M. Tan, J. Clin. Invest. 87, 68 (1991).
2. K. J. Bloch, W. W. Buchanan, M. J. Wohl, J. J. Bunim, Medicine 44, 187 (1965); E. K. L. Chan, J. C. Hamel, J. P. Buyon, E. M. Tan, J. Clin. Invest. 87, 68 (1991).
3. R. I. Fox et al., Arthritis Rheum. 29, 577 (1986); A. K. Kruize, R. J. T. Smeenk, L. Kater, Immunol. Today 16, 557 (1995).
4. R. I. Fox et al., Arthritis Rheum. 29, 577 (1986); A. K. Kruize, R. J. T. Smeenk, L. Kater, Immunol. Today 16, 557 (1995).
5. N. Haneji, H. Hamano, K. Yanagi, Y. Hayashi, J. Immunol. 153, 2769 (1994).
6. The salivary gland homogenates from 3d-Tx NFS/sld mice were prepared in 20 mM tris-HCl buffer (pH 7.2) containing 0.15 M NaCl and proteinase inhibitors (5 mM benzamidine-HCl, 2 mM diisopropyl fluoride, and 2 mM EDTA). The supernatant of the homogenates was fractionated on a Superose 12HR column (Pharmacia) and further purified on a DEAE-Cosmogel column (Nakarai, Japan). SDS-polyacrylamide gel electrophoresis was carried out in 10% gels as described by (28).
7. R. T. Moon and A. P. McMahon, J. Biol. Chem. 265, 4427 (1990); C. S. Birkenmeier et al., Proc. Natl. Acad. Sci. U.S.A. 82, 5671 (1985); M. D. Adams et al., Science 252, 1651 (1991).
8. R. T. Moon and A. P. McMahon, J. Biol. Chem. 265, 4427 (1990); C. S. Birkenmeier et al., Proc. Natl. Acad. Sci. U.S.A. 82, 5671 (1985); M. D. Adams et al., Science 252, 1651 (1991).
9. R. T. Moon and A. P. McMahon, J. Biol. Chem. 265, 4427 (1990); C. S. Birkenmeier et al., Proc. Natl. Acad. Sci. U.S.A. 82, 5671 (1985); M. D. Adams et al., Science 252, 1651 (1991).
10. Single-letter abbreviations for the amino acid residues are as follows: A, Ala; C, Cys; D, Asp; E, Glu; F, Phe; G, Gly; H, His; I, Ile; K, Lys; L, Leu; M, Met; N, Asn; P, Pro; Q, Gln; R, Arg; S, Ser; T, Thr; V, Val; W, Trp; and Y, Tyr.
11. 3H]thymidine was added per well, and the incorporated radioactivity was determined.
12. The amounts of IFN-γ and IL-2 produced were measured by enzyme-linked immunosorbent assay (ELISA) (29) with IFN-γ - specific monoclonal antibodies (Pharmingen) and mlL-2 ELISA system (Amersham).
13. A synthetic peptide of α-fodrin corresponding to the identified 20-amino acid residues [RQKLEDSYRFQFFQRDAEEL) (6)] was produced with an Applied Biosystems model 430A peptide synthesizer. Polyclonal rabbit antibody to the synthetic peptide was developed and affinity purified. Rabbit serum to the synthetic peptide was diluted 1:25 when used for protein immunoblots.
14. For immunohistochemistry, formalin-fixed paraffin-embedded salivary gland sections were deparaffinized in xylen and hydrated in ethanol. Sections were stained with polyclonal rabbit antibody to synthetic α-fodrin peptide diluted 1:500 dilution in 10% (v/v) fetal bovine serum, followed by incubation with biotin-labeled goat serum to rabbit as the linking antibody. After the preparations were rinsed, binding was detected with an avidin-biotin-peroxidase complex (Vector Laboratories, Burlingame, CA). Specificity of the staining was confirmed by the observation that incubating polyclonal rabbit antiserum with synthetic peptide completely blocked staining.
15. JS-1 cDNA encoding the human nonerythroid α-fodrin cDNA was constructed by inserting cDNA (base pairs 1 through 1784) into the Eco RI site of plasmid pGEX-2T (Pharmacia). GST fusion protein was expressed and purified with a GST gene fusion system (Pharmacia) as described (30). Protein immunoblots were performed and proliferative T cell responses were determined as described in the legend to Fig. 1.
16. S. C. White and G. W. Casarett, J. Immunol. 112, 178 (1974).
17. 3H]thymidine was added per well. Incorporation was measured by liquid scintillation counting.
18. J. R. Glenney, P. Glenney, K. Weber, J. Biol. Chem. 257, 9781 (1982).
19. D. Perrin and D. Aunis, Nature 315, 589 (1985); D. Perrin, O. K. Langley, D. Aunis, ibid. 326, 498 (1987).
20. D. Perrin and D. Aunis, Nature 315, 589 (1985); D. Perrin, O. K. Langley, D. Aunis, ibid. 326, 498 (1987).
21. D. Perrin, K. Möller, K. Hanke, H.-D. Söling, J. Cell Biol. 116, 127 (1992).
22. J. H. Hartwig, ibid. 118, 1421 (1992).
23. T. L. Leto et al., J. Biol. Chem. 264, 5826 (1989).
24. V. B. Lokeshwar and L. Y. W. Bourguignon, ibid. 267, 21551 (1992).
25. T. C. Saldo et al., ibid. 268, 25239 (1993).
26. S. J. Martin et al., ibid. 270, 6425 (1995).
27. J. Van de Water et al., J. Exp. Med. 167, 1791 (1988).
28. L. Portmann, N. Hamada, G. Heinrich, L. J. Degroot, J. Clin. Endocrinol. Metab. 6, 1001 (1985).
29. S. Backkeskov et al., Nature 347, 151 (1990); R. Tisch et al., ibid. 366, 72 (1993).
30. S. Backkeskov et al., Nature 347, 151 (1990); R. Tisch et al., ibid. 366, 72 (1993).
31. F. A. Karlsson, P. Burman, L. Loot, S. Mardh, J. Clin. Invest. 81, 475 (1988).
32. D. A. Stetler et al., Proc. Natl. Acad. Sci. U.S.A. 79, 6499 (1982).
33. D. C. Hooper, Immunol. Today 8, 327 (1987).
34. U. K. Laemmli, Nature 227, 680 (1970).
35. E. Macy, M. Kemeny, A. Saxon, FASEB J. 2, 3003 (1988).
36. I. Oadri, H. F. Maguire, A. Siddiqui, Proc. Natl. Acad. Sci. U.S.A. 92, 1003 (1995).
37. We thank S. Sone and K. Hoil for human sera and R. T. Moon for cDNA. Supported by grants-in-aid for scientic research from the Ministry of Education, Science, and Culture of Japan.